Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction

被引:10
作者
Miyao, Y [1 ]
Miyazaki, S [1 ]
Goto, Y [1 ]
Itoh, A [1 ]
Daikoku, S [1 ]
Morii, I [1 ]
Matsumoto, T [1 ]
Nonogi, H [1 ]
机构
[1] Natl Cardiovasc Ctr, Dept Internal Med, Div Cardiol, Osaka 5658565, Japan
来源
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 1999年 / 63卷 / 05期
关键词
acute myocardial infarction; platelet activating factor; soluble E-selectin;
D O I
10.1253/jcj.63.362
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
Although acute myocardial infarction (AMI) may involve both plaque rupture and ischemia-reperfusion injury, the pathogenesis of these phenomena is unclear. To elucidate the pathogenesis of AMI, serial measurements of platelet activating factor (PAF), interleukin-ti and cell adhesion molecules were made in patients with AMI. The PAF levels were measured upon hospital admission and at 24 and 72 h in 8 patients with AMI. Serum levels of interleukin-6, soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule-1 and soluble Vascular cell adhesion molecule-1 (sVCAM-1) were measured upon admission and at 24 h and 4 weeks in 30 patients with AMI and 15 patients with stable effort angina, PAF levels were higher in patients with AMI than in normal volunteers; the increased levels lasting at least 72 h. In contrast, interleukin-6 increased at 24 h, sE-selectin was elevated at admission and sVCAM-1 increased later. sE-selectin levels upon admission in patients with additional ST-segment elevation after reperfusion were significantly higher than those in patients without ST-elevation. In patients with AMI, the time-course of changes in blood levels of cytokines varied according to the individual substances. Although it Is unclear what is the precise role of each of the cytokines in the pathophysiology of AMI, sE-selectin may be possibly related to the reperfusion injury in the infarcted myocardium.
引用
收藏
页码:362 / 366
页数:5
相关论文
共 30 条
[1]   E-SELECTIN IN THE PATHOGENESIS OF EXPERIMENTAL MYOCARDIAL ISCHEMIA-REPERFUSION INJURY [J].
ALTAVILLA, D ;
SQUADRITO, F ;
IOCULANO, M ;
CANALE, P ;
CAMPO, GM ;
ZINGARELLI, B ;
CAPUTI, AP .
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1994, 270 (01) :45-51
[2]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[3]   MYOCARDIAL REPERFUSION - A DOUBLE-EDGED SWORD [J].
BRAUNWALD, E ;
KLONER, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1713-1719
[4]   AH23848, A THROMBOXANE ANTAGONIST, SUPPRESSES ISCHEMIA AND REPERFUSION-INDUCED ARRHYTHMIAS IN ANESTHETIZED GREYHOUNDS [J].
COKER, SJ ;
PARRATT, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (01) :259-264
[5]  
FALK E, 1983, BRIT HEART J, V50, P127
[6]   CIRCULATING ADHESION MOLECULES IN DISEASE [J].
GEARING, AJH ;
NEWMAN, W .
IMMUNOLOGY TODAY, 1993, 14 (10) :506-512
[7]   Reperfusion phenomena suggestive of reperfusion injury in patients with acute myocardial infarction [J].
Goto Y. ;
Ito T. ;
Matsumoto T. ;
Morii I. ;
Miyao Y. ;
Ito A. ;
Daikoku S. ;
Miyazaki S. ;
Nonogi H. .
Journal of Thrombosis and Thrombolysis, 1997, 4 (1) :39-41
[8]   GINKGOLIDE-B PROTECTS ISOLATED HEARTS AGAINST ARRHYTHMIAS INDUCED BY ISCHEMIA BUT NOT REPERFUSION [J].
KOLTAI, M ;
TOSAKI, A ;
HOSFORD, D ;
BRAQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (02) :293-302
[9]  
LATINI R, 1994, J CARDIOVASC PHARM, V23, P1, DOI 10.1097/00005344-199401000-00001
[10]   A NOVEL SIALYL LEWIS(X) ANALOG ATTENUATES NEUTROPHIL ACCUMULATION AND MYOCARDIAL NECROSIS AFTER ISCHEMIA AND REPERFUSION [J].
LEFER, DJ ;
FLYNN, DM ;
PHILLIPS, ML ;
RATCLIFFE, M ;
BUDA, AJ .
CIRCULATION, 1994, 90 (05) :2390-2401